Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-390510

Chief Medical Officer sold 10,028 shares at an average $32.40 ($324,868)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-10 Sale : show line 1 in the form −7,947 $32.21 $256,004 280,145 D
2026-09-10 Sale : show line 2 in the form −2,081 $33.09 $68,864 278,064 D
Open-market sales · 10,028 sh · avg $32.40 · $324,868
Loading xslF345X06/ownership.xml…